PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Pathogenic Biology, Hengyang Medical College, University of South China, Hengyang, China.\', \'Department of Clinical Laboratory, Hengyang Central Hospital, Hengyang, China.\', \'Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.821538
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35126377
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35126377>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35126377>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all